In osteosarcoma, dysregulated cholesterol biosynthesis has been linked to enhanced survival and migration (Pasello et al., 2022), with key enzymes such as sterol regulatory element-binding protein 1 (SREBP1) contributing to oncogenic phenotypes (Huang X. et al., 2024). This evidence concerns the gene SREBF1 and osteosarcoma.